MAPT and Alzheimer disease: However, [18F]Br-BIPF (Figure 9d), [18F]Cl-BIPF (Figure 9e), [18F]Me-BIPF (Figure 9f), and [18F]OMe-BIP (Figure 9g) have also shown appropriate binding to tau aggregates in AD brain sections [201,202].